Skip to content
2000
Volume 4, Issue 6
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In placebo-controlled clinical studies, lamotrigine has been shown to be effective in reducing seizure frequency and the number of days with seizures when added to existing antiepileptic drug therapy in adult patients with partial seizures, with or without generalized tonic-clonic seizures, that are not satisfactorily controlled. Lamotrigine has emerged as a first line treatment for bipolar depression, which is an area of weakness for other mood stabilizers, with positive effect for resistant bipolar disorders and rapid cycling bipolar disorders. We review the Literature on the topic with a specific interest on bipolar disorders.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/157018007781387836
2007-09-01
2025-05-31
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/157018007781387836
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test